Key points are not available for this paper at this time.
The analysis of phytoconstituents present in the dichloromethane extract of the bulb of Hippeastrum vittatum (L’Her.) Herb., Proiphys amboinensis (L.) Herb., Urceolina amazonica (Linden) Christenh. In Hymenocallis littoralis was Liriodendromin (14.03%), Linoleic acid ethyl ester (11.91%) and Ethyl oleate (9.38%); in Zephranthes carinata; Phthalic acid, 4-methoxybenzyl methyl ester (15.34%) Gatanthamine, 3-O-acetyl-1, 2, dihydro (8.87%) Stigmasterol (5.87%); in Hippeastrum vittatum; N-benzyl-2-[1-(4-methoxyl-phenyl 1) – 1 H-tetrazo (14.94%), Benzaminde, 2-amino-N-(4-ethoxyphenyl) (12.65%) and 1-(5-methyl-2-hydroxyphenyl)-3-phenyl propane (10.49%); in Crinum jagus; 2H-1-Benzopyran-7-ol, 3,4-dihydro-3-(2-hyrdo) (19.87%), Benzamide, 2-amino-N- (4-ethoxyphenyl) (9.92%) and Stigmasterol (4.04%); in Proiphys amboniensis; Gamma-sitosterol (16.98%), Stigmasterol (11.49%) and N-Hexadecanoic acid(5.05%); in U. amazonica; 3-Furanacetic acid, 4-hexyl-2, 5-dihydro-2, 5 (12.73%), Benzamide, 2-amino-N- (4-ethoxyphenyl) (8.18%) and Phenyl, 2-(3,4-dihydro 2-methoxyl-2H-1-benzopy) (6.40%). The presence of various bioactive compounds may be responsible for the application of these species in the treatment and management of various ailments in folklore medicine. However, in vitro and in vivo studies, isolation of individual phytoconstituents and their mechanism of action may proceed to find a novel drug or lead compound for use as medicine.
Bassey et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: